2-Benzylthio-N6-isopentenyladenine | 52172-11-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 2-Benzylthio-N6-isopentenyladenine
• 英文别名: 2-benzylsulfanyl-N-(3-methylbut-3-enyl)-7H-purin-6-amine
• CAS: 52172-11-9
• 化学式: C₁₇H₁₉N₅S
• 分子量: 325.4
• InChiKey: GVYHKHKNGPAILF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  23
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  91.8
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• Methods and compositions for increasing fermentation of a microorganism
  申请人：Miljkovic Dusan

  公开号：US20050042327A1

  公开（公告）日：2005-02-24

  Fermentation of a microorganism is increased by including a cytokinin into the fermentation medium. Contemplated cytokinins may be synthetic cytokinins, cytokinins isolated from a natural source, or present in an extract that is specifically enriched for cytokinins. Especially contemplated microorganisms include yeast, and the fermentation in preferred aspects comprises catabolic conversion of a carbohydrate to ethanol and/or carbon dioxide.
• Alimentary compositions and methods for metabolic modulation
  申请人：Miljkovic Dusan

  公开号：US20070184067A1

  公开（公告）日：2007-08-09

  Contemplated food products include compounds with cytokinin activity to modulate glucose and/or lipid metabolism, and in especially preferred aspects contemplated food products include one or more naturally occurring cytokinins (e.g., kinetin, N2-acetylguanine, zeatin, dihydrozeatin) at a concentration effective to prevent or treat pre-diabetes, insulin resistance, type-2 diabetes, syndrome X, and/or dyslipidemia. Methods of marketing such products are also contemplated.
• Alimentary Compositions and Methods For Metabolic Modulation
  申请人：Miljkovic Dusan

  公开号：US20090208620A1

  公开（公告）日：2009-08-20

  Contemplated food products include compounds with cytokinin activity to modulate glucose and/or lipid metabolism, and in especially preferred aspects contemplated food products include one or more naturally occurring cytokinins (e.g., kinetin, N2-acetylguanine, zeatin, dihydrozeatin) at a concentration effective to prevent or treat pre-diabetes, insulin resistance, type-2 diabetes, syndrome X, and/or dyslipidemia. Methods of marketing such products are also contemplated.
• Methods and Compositions For Increasing Fermentation of a Microorganism
  申请人：Miljkovic Dusan

  公开号：US20090214710A1

  公开（公告）日：2009-08-27

  Fermentation of a microorganism is increased by including a cytokinin into the fermentation medium. Contemplated cytokinins may be synthetic cytokinins, cytokinins isolated from a natural source, or present in an extract that is specifically enriched for cytokinins. Especially contemplated microorganisms include yeast, and the fermentation in preferred aspects comprises catabolic conversion of a carbohydrate to ethanol and/or carbon dioxide.
• [EN] PHARMACEUTICAL COMPOSITIONS AND METHODS FOR METABOLIC MODULATION<br/>[FR] COMPOSITIONS PHARMACEUTIQUES ET PROCEDES DE MODULATION METABOLIQUE
  申请人：VDF FUTURECEUTICALS

  公开号：WO2005020892A2

  公开（公告）日：2005-03-10

  Pharmaceutical compositions include compounds with cytokinin activity to modulate glucose and/or lipid metabolism in a mammal. Especially preferred compounds include those comprising a purine scaffold, and it is further preferred that contemplated compositions are employed to prevent and/or treat various diseases, including pre-diabetes, insulin resistance, type-2 diabetes, Syndrome X, and dyslipidemia. In still further preferred aspects, compounds with cytokinin activity are used to activate AMPK and/or Akt. Consequently, various diseases associated with dysregulation of AMPK and/or Akt may be treated using the compounds of the present inventive subject matter.